Come join us at the Tau Ventures 8th Annual Day in Palo Alto on July 23, 2026! This is always our biggest event of the year and we expect a completely full house. Sign up here!
HIGHLIGHTS
Assort Health (Fund II / Opty) announced a $120M Series C led by Menlo Ventures at a valuation of $1.2 billion
We’ve kicked off fundraising for Fund III: learn more by emailing us at [email protected]
PORTFOLIO
Automating revenue integrity for healthcare payors (Fund I / Opty | Co-investors: Transformation, FirstMark, Anthemis, Aperture, 1984)
Released a new case study showing how a regional payor realized $21M of savings by using Alaffia
Agentic AI and workflow automation platform reducing administrative burden for payors, pharma and life sciences companies (Opty | Co-investors: Valtruis, Cigna, ATX, Capital Factory)
Selected by the World Economic Forum as a Technology Pioneer
The AI-assisted EHR for therapists (Opty | Co-investors: Ensemble, Lightbank, Bonfire, Revolution)
CEO Danny Freed joined The Mental Health Coffee Break podcast to discuss Blueprint and where he thinks AI fits in mental health care
AI-enabled ambulatory surgery centers and operating system (Opty | Co-investors: FPV Ventures, McKesson Ventures, Black Opal, OSE, Rogue VC)
Named to Fast Company's World Changing Ideas list
AI-enabled whole-member intelligence for community health plans (Fund II | Co-investors: AlleyCorp, A-Squared, Bull City)
Launched new podcast, Mission & Margin, bringing together leaders from across the industry to discuss the difficult decisions health plans are facing and how to navigate a rapidly changing market
Real-time glucose insights to drive smarter weight loss (Fund I | Co-investors: GV, Cheyene, Samsung Next, Courtside, 1984)
Recent study showed that Signos drives up to 7% weight loss over 6 months, rivaling real-world GLP-1 weight loss
DevSecOps focused on application security (Fund I / Opty | Co-investors: Highland, NGP, Ballistic, Sierra, Cervin)
Released 90-day Claude Mythos readiness blueprint for AI-scale vulnerability management
The data factory for AI development (Fund I / Opty | Co-investors: Kleiner, Softbank, a16z)
Launched Recursion, a reinforcement learning platform for building enterprise specialist agents
Digital twins of employees (Opty | Co-investors: Khosla, Foundation, FPV Ventures)
FOUNDER SPOTLIGHT
CEO & Co-Founder of Fourier
Turning unstructured clinical data into labeled data sets, pre-appointment checklists and case summaries (Fund II | Co-investors: Yosemite, Innospark, NextGen)
Share your background and the story behind starting your company:
Previously I built and sold an expert medical opinion business where I used to collect a TON of complex and voluminous records. In order to make the process more seamless for our expert physicians, we had a whole separate network of junior staff who would reconcile and summarize the collected records into something easier to digest. With the advent of LLMs, I realized this in itself was a much bigger opportunity. The process that goes into how a complex clinical deliverable is created…is the product missing across the healthcare LLM tech stack. We have the vision to be the leading RL environment and source of contextual healthcare data.
What problems are you solving, and how do you provide value to your customers?
To providers: Operational lift and OpEx. On average we save 45-60 mins of clinical and admin time per patient. We find critical missing info in 77% of all patients. We at minimum demonstrate 4:1 hard dollar ROI.
LLM Benchmarking: We are 20-30x higher performing than all frontier models. We are even 3.5x more accurate than human clinicians on the same tasks. We average F1 >0.96 for all clinical tasks.
What have you enjoyed most about collaborating with Tau Ventures?
Two things. 1) Tau is always reliable to help you with some of your most hairy problems. You never know where a quick text you fire off can lead you. 2) The network and connectivity is crazy and am very grateful to be in it!